{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:58:07Z","timestamp":1793404687762,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Sarcoidosis is a systemic inflammatory disease of unknown origin, which consists of the formation of multiple sterile noncaseating granulomas. Inhaled antigens are believed to initiate disease in prone individuals, considering that almost all patients present pulmonary or mediastinal lymph node disease. Extrapulmonary manifestations are common and diverse: practically any organ system can be affected, and treatment can range from simple watchful waiting to intense immunosuppression. In this article, we review current concepts about sarcoidosis in an overview, focusing on recognition and treatment of its major clinical phenotypes.<\/jats:p>","DOI":"10.1186\/s42358-024-00381-z","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T05:03:22Z","timestamp":1723439002000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Sarcoidosis: a general overview"],"prefix":"10.1186","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8725-4526","authenticated-orcid":false,"given":"Fabricio Souza","family":"Neves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivanio Alves","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Sztajnbok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilton Salles Rosa","family":"Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,12]]},"reference":[{"key":"381_CR1","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/joim.13629","volume":"293","author":"M Rossides","year":"2023","unstructured":"Rossides M, Darlington P, Kullberg S, Arkema EV. Sarcoidosis: Epidemiology and clinical insights. J Intern Med. 2023;293:668\u201380. https:\/\/doi.org\/10.1111\/joim.13629.","journal-title":"J Intern Med"},{"key":"381_CR2","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1165\/rcmb.2014-0227OC","volume":"53","author":"MA Levin","year":"2015","unstructured":"Levin MA, Adrianto I, Datta I, et al. Association of HLA-DRB1 with Sarcoidosis susceptibility and progression in African americans. Am J Respir Cell Mol Biol. 2015;53:206\u201316. https:\/\/doi.org\/10.1165\/rcmb.2014-0227OC.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"381_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1094843","author":"K Sikorova","year":"2023","unstructured":"Sikorova K, Osoegawa K, Kocourkova L, et al. Association between sarcoidosis and HLA polymorphisms in a Czech population from Central Europe: focus on a relationship with clinical outcome and treatment. Front Med. 2023. https:\/\/doi.org\/10.3389\/fmed.2023.1094843.","journal-title":"Front Med"},{"key":"381_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12929-019-0537-6","volume":"26","author":"PT Inaoka","year":"2019","unstructured":"Inaoka PT, Shono N, Kamada M, Espinoza JL. Host-microbe interactions in the pathogenesis and clinical course of sarcoidosis. J Biomed Sci. 2019;26:45. https:\/\/doi.org\/10.1186\/s12929-019-0537-6.","journal-title":"J Biomed Sci"},{"issue":"9","key":"381_CR5","doi-asserted-by":"publisher","first-page":"e038926","DOI":"10.1136\/bmjopen-2020-038926","volume":"10","author":"P Graff","year":"2020","unstructured":"Graff P, Larsson J, Bryngelsson IL, Wiebert P, Wihlborg P. Sarcoidosis and silica dust exposure among men in Sweden: a case-control study. BMJ Open. 2020;10(9):e038926. https:\/\/doi.org\/10.1136\/bmjopen-2020-038926.","journal-title":"BMJ Open"},{"key":"381_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12931-020-01409-w","volume":"21","author":"E Beijer","year":"2020","unstructured":"Beijer E, Meek B, Bossuyt X, et al. Immunoreactivity to metal and silica associates with sarcoidosis in Dutch patients. Respir Res. 2020;21:141. https:\/\/doi.org\/10.1186\/s12931-020-01409-w.","journal-title":"Respir Res"},{"key":"381_CR7","doi-asserted-by":"publisher","unstructured":"Greaves AS, Atif SM, Fontenot AP. eCollection. Adaptive Immunity in Pulmonary Sarcoidosis and Chronic Beryllium Disease. Front Immunol 2020:11:474. https:\/\/doi.org\/10.3389\/fimmu.2020.00474. 2020.","DOI":"10.3389\/fimmu.2020.00474"},{"key":"381_CR8","doi-asserted-by":"publisher","unstructured":"Cooper D, Suau S, Sarcoidosis. Immunol Allergy Clin N Am. 2023;583\u201391. https:\/\/doi.org\/10.1016\/j.iac.2022.10.011.","DOI":"10.1016\/j.iac.2022.10.011"},{"key":"381_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.05.2011.4278","author":"F Binesh","year":"2012","unstructured":"Binesh F, Halvani H, Navabii H. BMJ Case Rep. 2012. https:\/\/doi.org\/10.1136\/bcr.05.2011.4278. bcr0520114278.","journal-title":"BMJ Case Rep"},{"key":"381_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12890-020-01191-x","volume":"20","author":"HS Te","year":"2020","unstructured":"Te HS, Perlman DM, Shenoy C, et al. Clinical characteristics and organ system involvement in sarcoidosis: comparison of the University of Minnesota Cohort with other cohorts. BMC Pulm Med. 2020;20:155. https:\/\/doi.org\/10.1186\/s12890-020-01191-x.","journal-title":"BMC Pulm Med"},{"key":"381_CR11","doi-asserted-by":"publisher","unstructured":"Shupp JC, Freitag-Wolf S, Bargagli E et al. Phenotypes of organ involvement in sarcoidosis. Eur Resp J 2018 51: 1700991. https:\/\/doi.org\/10.1183\/13993003.00991-2017.","DOI":"10.1183\/13993003.00991-2017"},{"key":"381_CR12","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1136\/bmj.2.5261.1165","volume":"2","author":"JG Scadding","year":"1961","unstructured":"Scadding JG. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years\u2019 observation. Br Med J. 1961;2:1165\u201372. https:\/\/doi.org\/10.1136\/bmj.2.5261.1165.","journal-title":"Br Med J"},{"key":"381_CR13","doi-asserted-by":"publisher","unstructured":"Levy A, Hamzeh N, Maier LA, F1000Res. Is it time to scrap Scadding and adopt computed tomography for initial evaluation of sarcoidosis?. 2018; 7: F1000 Faculty Rev-600. https:\/\/doi.org\/10.12688\/f1000research.11068.1.","DOI":"10.12688\/f1000research.11068.1"},{"key":"381_CR14","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/s0002-9343(99)00223-5","volume":"107","author":"J Ma\u00f1a","year":"1999","unstructured":"Ma\u00f1a J, G\u00f3mez-Vaquero C, Montero A, et al. L\u00f6fgren\u2019s syndrome revisited: a study of 186 patients. Am J Med. 1999;107:240\u20132455. https:\/\/doi.org\/10.1016\/s0002-9343(99)00223-5.","journal-title":"Am J Med"},{"key":"381_CR15","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1080\/08998280.2013.11929014","volume":"26","author":"MC Denny","year":"2013","unstructured":"Denny MC, Fotino AD. The Heerfordt-Waldenstr\u00f6m syndrome as an initial presentation of sarcoidosis. Proc (Bayl Univ Med Cent). 2013;26:390. https:\/\/doi.org\/10.1080\/08998280.2013.11929014.","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"381_CR16","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/resp.14182","volume":"27","author":"LMM Crombag","year":"2022","unstructured":"Crombag LMM, Moij-Kalverda K, Szlubowski A, et al. EBUS versus EUS-B for diagnosing sarcoidosis: the International Sarcoidosis Assessment (ISA) randomized clinical trial. Respirology. 2022;27:152\u201360. https:\/\/doi.org\/10.1111\/resp.14182.","journal-title":"Respirology"},{"key":"381_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12931-020-1327-0","volume":"21","author":"P Darlinton","year":"2020","unstructured":"Darlinton P, Kullberg S, Eklund A, et al. Lung CD4\u2009+\u2009V\u03b12.3\u2009+\u2009T-cells in sarcoidosis cohorts with L\u00f6fgren\u2019s syndrome. Respir Res. 2020;21:61. https:\/\/doi.org\/10.1186\/s12931-020-1327-0.","journal-title":"Respir Res"},{"key":"381_CR18","doi-asserted-by":"publisher","unstructured":"Shen Y, Pang C, Wu Y et al. Diagnostic performance of Bronchoalveolar Lavage Fluid CD4\/CD8 ratio for sarcoidosis: a Meta-analysis. EBioMedicine 2016:8:302\u20138. https:\/\/doi.org\/10.1016\/j.ebiom.2016.04.024.","DOI":"10.1016\/j.ebiom.2016.04.024"},{"key":"381_CR19","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1055\/s-0030-1262207","volume":"31","author":"U Costabel","year":"2010","unstructured":"Costabel U, Bonella F, Ohshimo S, Guzman J. Diagnostic modalities in sarcoidosis: BAL, EBUS, and PET. Semin Respir Crit Care Med. 2010;31:404. https:\/\/doi.org\/10.1055\/s-0030-1262207.","journal-title":"Semin Respir Crit Care Med"},{"key":"381_CR20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/1744666X.2019.1568240","volume":"15","author":"M Ramos-Casals","year":"2019","unstructured":"Ramos-Casals M, Retamozo S, Sis\u00f3-Almiral A, et al. Clinically-useful serum biomarkers for diagnosis and prognosis of sarcoidosis. Expert Rev Clin Immunol. 2019;15:391\u2013405. https:\/\/doi.org\/10.1080\/1744666X.2019.1568240.","journal-title":"Expert Rev Clin Immunol"},{"key":"381_CR21","doi-asserted-by":"publisher","first-page":"190146","DOI":"10.1183\/16000617.0146-2019","volume":"29","author":"FF Rahaghi","year":"2020","unstructured":"Rahaghi FF, Baughman RP, Saketkoo LA, et al. Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis. Eur Respir Rev. 2020;29:190146. https:\/\/doi.org\/10.1183\/16000617.0146-2019.","journal-title":"Eur Respir Rev"},{"key":"381_CR22","doi-asserted-by":"publisher","first-page":"e2023011","DOI":"10.36141\/svdld.v40i1.14396","volume":"40","author":"RP Baughman","year":"2023","unstructured":"Baughman RP, Niranjan V, Walker G, et al. Efzofitimod: a novel anti-inflammatory agent for sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2023;40:e2023011. https:\/\/doi.org\/10.36141\/svdld.v40i1.14396.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"381_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-019-0096-x","volume":"5","author":"J Grunewald","year":"2019","unstructured":"Grunewald J, Grutters JC, Arkema EV, et al. Sarcoidosis Nat Rev Dis Primers. 2019;5:45. https:\/\/doi.org\/10.1038\/s41572-019-0096-x.","journal-title":"Sarcoidosis Nat Rev Dis Primers"},{"key":"381_CR24","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJMra2101555","volume":"385","author":"M Drent","year":"2021","unstructured":"Drent M, Crouser ED, Grunewald J. Challenges of Sarcoidosis and its management. N Engl J Med. 2021;385:1018\u201332. https:\/\/doi.org\/10.1056\/NEJMra2101555.","journal-title":"N Engl J Med"},{"key":"381_CR25","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/MCP.0000000000000997","volume":"29","author":"MTHF Janssen","year":"2023","unstructured":"Janssen MTHF, Landew\u00e9 RBM, Post MC, et al. Organ involvement and assessment in sarcoidosis. Curr Opin Pulm Med. 2023;29:485\u201392. https:\/\/doi.org\/10.1097\/MCP.0000000000000997.","journal-title":"Curr Opin Pulm Med"},{"key":"381_CR26","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1183\/09031936.00051907","volume":"31","author":"MA Judson","year":"2008","unstructured":"Judson MA, Baughman RP, Costabel U, et al. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J. 2008;31:1189. https:\/\/doi.org\/10.1183\/09031936.00051907.","journal-title":"Eur Respir J"},{"key":"381_CR27","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ophtha.2006.05.074","volume":"114","author":"M Evans","year":"2007","unstructured":"Evans M, Sharma O, LaBree L, Smith RE, Rao NA. Differences in clinical findings between caucasians and African americans with biopsy-proven sarcoidosis. Ophthalmology. 2007;114:325\u201333. https:\/\/doi.org\/10.1016\/j.ophtha.2006.05.074.","journal-title":"Ophthalmology"},{"key":"381_CR28","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","volume":"201","author":"ED Crouser","year":"2020","unstructured":"Crouser ED, Maier LA, Wilson KC, et al. Diagnosis and detection of Sarcoidosis. An official American thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020;201:e26. https:\/\/doi.org\/10.1164\/rccm.202002-0251ST.","journal-title":"Am J Respir Crit Care Med"},{"key":"381_CR29","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1055\/s-0040-1710536","volume":"41","author":"P S\u00e8ve","year":"2020","unstructured":"S\u00e8ve P, Jamilloux Y, Tilikete C, et al. Ocular Sarcoidosis. Semin Respir Crit Care Med. 2020;41:673\u201388. https:\/\/doi.org\/10.1055\/s-0040-1710536.","journal-title":"Semin Respir Crit Care Med"},{"key":"381_CR30","doi-asserted-by":"publisher","unstructured":"Mochizuki M, Smith JR, Takase H, et al. Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br J Ophthalmol. 2019;103:1418. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-313356.","DOI":"10.1136\/bjophthalmol-2018-313356"},{"key":"381_CR31","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2147\/OPTH.S128949","volume":"12","author":"A Matsou","year":"2018","unstructured":"Matsou A, Tsaousis TT. Management of chronic ocular sarcoidosis: challenges and solutions. Clin Ophthalmol. 2018;12:519\u201332. https:\/\/doi.org\/10.2147\/OPTH.S128949.","journal-title":"Clin Ophthalmol"},{"key":"381_CR32","doi-asserted-by":"publisher","first-page":"699e1","DOI":"10.1016\/j.jaad.2011.11.965","volume":"66","author":"A Haimovic","year":"2012","unstructured":"Haimovic A, Sanchez M, Judson MA, Prystowsky S. Sarcoidosis: a comprehensive review and update for the dermatologist: part I. cutaneous disease. J Am Acad Dermatol. 2012;66:699e1. https:\/\/doi.org\/10.1016\/j.jaad.2011.11.965.","journal-title":"J Am Acad Dermatol"},{"key":"381_CR33","doi-asserted-by":"publisher","unstructured":"Marchell RM, Judson MA. Cutaneous sarcoidosis. Semin Respir Crit Care Med. 2010;31:442\u201351. https:\/\/doi.org\/10.1055\/s-0030-1262212.","DOI":"10.1055\/s-0030-1262212"},{"key":"381_CR34","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.amjms.2017.08.009","volume":"355","author":"Y Yatsynovich","year":"2018","unstructured":"Yatsynovich Y, Dittoe N, Petrov M, et al. Cardiac sarcoidosis: a review of Contemporary challenges in diagnosis and treatment. Am J Med Sci. 2018;355:113\u201325. https:\/\/doi.org\/10.1016\/j.amjms.2017.08.009.","journal-title":"Am J Med Sci"},{"key":"381_CR35","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1111\/echo.13281","volume":"33","author":"G Murtagh","year":"2016","unstructured":"Murtagh G, Laffin LJ, Patel KV, et al. Improved detection of myocardial damage in sarcoidosis using longitudinal strain in patients with preserved left ventricular ejection fraction. Echocardiography. 2016;33:1344\u201352. https:\/\/doi.org\/10.1111\/echo.13281.","journal-title":"Echocardiography"},{"key":"381_CR36","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1136\/heartjnl-2019-316442","volume":"107","author":"V Kouranos","year":"2021","unstructured":"Kouranos V, Sharma R. Cardiac sarcoidosis: state-of-the-art review. Heart. 2021;107:1591\u20139. https:\/\/doi.org\/10.1136\/heartjnl-2019-316442.","journal-title":"Heart"},{"key":"381_CR37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11886-020-01429-4","volume":"22","author":"SC Masri","year":"2020","unstructured":"Masri SC, Bellumkonda L. Sarcoid Heart Disease: an update on diagnosis and management. Curr Cardiol Rep. 2020;22:177. https:\/\/doi.org\/10.1007\/s11886-020-01429-4.","journal-title":"Curr Cardiol Rep"},{"key":"381_CR38","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/NRL.0b013e3181c92a72","volume":"16","author":"V Terushkin","year":"2010","unstructured":"Terushkin V, Stern BJ, Judson MA, et al. Neurosarcoidosis: presentations and management. Neurologist. 2010;16:2. https:\/\/doi.org\/10.1097\/NRL.0b013e3181c92a72.","journal-title":"Neurologist"},{"key":"381_CR39","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1097\/01.COC.0000077933.69101.5D","volume":"26","author":"MD Menninger","year":"2003","unstructured":"Menninger MD, Amdur RJ, Marcus RB Jr. Role of radiotherapy in the treatment of neurosarcoidosis. Am J Clin Onco. 2003;26:e115. https:\/\/doi.org\/10.1097\/01.COC.0000077933.69101.5D.","journal-title":"Am J Clin Onco"},{"key":"381_CR40","doi-asserted-by":"publisher","first-page":"106537","DOI":"10.1016\/j.rmed.2021.106537","volume":"187","author":"J Werner","year":"2021","unstructured":"Werner J, Rivera N, Grunewald J, et al. HLA-DRB1 alleles associate with hypercalcemia in sarcoidosis. Respir Med. 2021;187:106537. https:\/\/doi.org\/10.1016\/j.rmed.2021.106537.","journal-title":"Respir Med"},{"key":"381_CR41","doi-asserted-by":"publisher","first-page":"e2021017","DOI":"10.36141\/svdld.v38i3.11488","volume":"38","author":"F Rastelli","year":"2021","unstructured":"Rastelli F, Baragetti I, Buzzi L, et al. Renal involvement in sarcoidosis: histological patterns and prognosis, an Italian survey. Sarcoidosis Vasc Diffuse Lung Dis. 2021;38:e2021017. https:\/\/doi.org\/10.36141\/svdld.v38i3.11488.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"381_CR42","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1055\/s-2007-1006293","volume":"6","author":"A Sharma","year":"1992","unstructured":"Sharma A, Kadakia J, Sharma O. Gastrointestinal Sarcoidosis. Sem Respir Med. 1992;6:442. https:\/\/doi.org\/10.1055\/s-2007-1006293.","journal-title":"Sem Respir Med"},{"key":"381_CR43","doi-asserted-by":"publisher","unstructured":"Cremers JP, Drent M, Baughman RP et al. Therapeutic approach of hepatic sarcoidosis. Curr Opin Pulm Med;18:472\u201382. https:\/\/doi.org\/10.1097\/MCP.0b013e3283541626.","DOI":"10.1097\/MCP.0b013e3283541626"},{"key":"381_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.26564","author":"M Hang\u00fcl","year":"2023","unstructured":"Hang\u00fcl M, K\u00f6se M, Pekcan S, Ersoy A, Unal G, Caglar HT. Childhood sarcoidosis in the middle Anatolia of Turkey. Pediatr Pulmonol. 2023. https:\/\/doi.org\/10.1002\/ppul.26564.","journal-title":"Pediatr Pulmonol"},{"key":"381_CR45","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11882-021-00991-3","volume":"21","author":"K Kaufman","year":"2021","unstructured":"Kaufman K, Becker ML. Distinguishing Blau Syndrome from systemic sarcoidosis. Curr Allergy Asthma Rep. 2021;21:10. https:\/\/doi.org\/10.1007\/s11882-021-00991-3.","journal-title":"Curr Allergy Asthma Rep"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-024-00381-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42358-024-00381-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-024-00381-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T05:09:59Z","timestamp":1723439399000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-024-00381-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,12]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["381"],"URL":"https:\/\/doi.org\/10.1186\/s42358-024-00381-z","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,12]]},"assertion":[{"value":"2 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}